EIF3E

Chr 8

eukaryotic translation initiation factor 3 subunit E

Also known as: EIF3-P48, EIF3S6, INT6, eIF3-p46

Enables RNA binding activity and cadherin binding activity. Contributes to translation initiation factor activity. Involved in nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; positive regulation of translation; and translational initiation. Located in PML body and cytosol. Part of eukaryotic translation initiation factor 3 complex. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
11
Pubs (1 yr)
P/LP submissions
P/LP missense
0.53
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.53LOEUF
pLI 0.052
Z-score 3.29
OE 0.28 (0.160.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.13Z-score
OE missense 0.42 (0.360.50)
97 obs / 230.7 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.28 (0.160.53)
00.351.4
Missense OE?0.42 (0.360.50)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 7 / 24.7Missense obs/exp: 97 / 230.7Syn Z: -0.74

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

EIF3E · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →